Eric Tardif
Founder chez Maravai Life Sciences, Inc.
Profil
Eric Tardif a fondé Maravai Lifesciences Holdings, Inc. et Maravai Life Sciences, Inc. M. Tardif occupe le poste de président de Vector Laboratories, Inc, président et associé de Maravai Life Sciences, Inc et président de Maravai Lifesciences Holdings, Inc. Eric Tardif était auparavant vice-président principal de la stratégie d'entreprise chez Hologic, Inc. et vice-président principal du développement d'entreprise et du marketing chez Gen-Probe, Inc. (une filiale de Hologic, Inc.). Il a obtenu un diplôme de premier cycle de l'Université Bishop's, un MBA de l'Université de la Colombie-Britannique et un diplôme d'études supérieures du Boston College.
Postes actifs de Eric Tardif
| Sociétés | Poste | Début |
|---|---|---|
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Founder | 18/03/2014 |
Vector Laboratories, Inc.
 Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | President | - |
Anciens postes connus de Eric Tardif
| Sociétés | Poste | Fin |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Founder | 30/06/2021 |
| HOLOGIC, INC. | Corporate Officer/Principal | - |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 18/10/2011 |
Formation de Eric Tardif
| Boston College | Graduate Degree |
| University of British Columbia | Masters Business Admin |
| Bishop's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HOLOGIC, INC. | Health Technology |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | Process Industries |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |
